{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Wu Y"],"funding":["National Natural Science Foundation of China"],"pagination":["11932-11938"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9063552"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["9(21)"],"pubmed_abstract":["Three novel inorganic-organic hybrid materials [Co(btp)<sub>2</sub>(W<sub>5</sub>O<sub>16</sub>)(H<sub>2</sub>O)] <sub><i>n</i></sub> (1), [Cd<sub>3</sub>(btp)<sub>6</sub>(PW<sub>12</sub>O<sub>40</sub>)<sub>2</sub>(H<sub>2</sub>O)<sub>6</sub>·6H<sub>2</sub>O] <sub><i>n</i></sub> (2), and [Ag<sub>3</sub>(btp)<sub>2</sub>(PMo<sub>12</sub>O<sub>40</sub>)·1.5H<sub>2</sub>O] <sub><i>n</i></sub> (3) (btp = 2,6-bis(1,2,4-triazol-1-yl)pyridine) have been hydrothermally synthesized and characterized by IR spectroscopy, single-crystal X-ray diffraction, powder X-ray diffraction (PXRD), elemental analysis and thermal gravimetric analysis (TGA). The most striking structure feature of compound 1 is a 3D polycatenation framework, interpenetrated by a 2D 4-connected <b>sql</b> topology layer and a 3D 6-connected <b>rob</b> topology framework. Compound 2 exhibits a rare meso-helices 3D network with different chiralities crossing coexistence. Compound 3 also holds a 3D framework formed by linking terminal oxygen atoms of [α-PMo<sub>12</sub>O<sub>40</sub>]<sup>3-</sup> anions and silver ions in a 2D metal-organic layer. Compound 1 displays antiferromagnetic behavior. The luminescence, electrochemical and photocatalytic properties of compounds 1-3 have also been investigated. Compound 3 exhibits significant electrochemical activity for the reduction of H<sub>2</sub>O<sub>2</sub> while compounds 1 and 2 show efficient photocatalytic activities for the degradation of Rhodamine B (RhB). Furthermore, the three compounds display luminescence behaviors in the solid state."],"journal":["RSC advances"],"pubmed_title":["Three novel polyoxometalate-based inorganic-organic hybrid materials based on 2,6-bis(1,2,4-triazol-1-yl)pyridine."],"pmcid":["PMC9063552"],"funding_grant_id":["21403053","U1504209"],"pubmed_authors":["Li X","Liu Y","Li Y","Huang Y","Xiao G","Dang D","Bai Y","Wu Y"],"additional_accession":[]},"is_claimable":false,"name":"Three novel polyoxometalate-based inorganic-organic hybrid materials based on 2,6-bis(1,2,4-triazol-1-yl)pyridine.","description":"Three novel inorganic-organic hybrid materials [Co(btp)<sub>2</sub>(W<sub>5</sub>O<sub>16</sub>)(H<sub>2</sub>O)] <sub><i>n</i></sub> (1), [Cd<sub>3</sub>(btp)<sub>6</sub>(PW<sub>12</sub>O<sub>40</sub>)<sub>2</sub>(H<sub>2</sub>O)<sub>6</sub>·6H<sub>2</sub>O] <sub><i>n</i></sub> (2), and [Ag<sub>3</sub>(btp)<sub>2</sub>(PMo<sub>12</sub>O<sub>40</sub>)·1.5H<sub>2</sub>O] <sub><i>n</i></sub> (3) (btp = 2,6-bis(1,2,4-triazol-1-yl)pyridine) have been hydrothermally synthesized and characterized by IR spectroscopy, single-crystal X-ray diffraction, powder X-ray diffraction (PXRD), elemental analysis and thermal gravimetric analysis (TGA). The most striking structure feature of compound 1 is a 3D polycatenation framework, interpenetrated by a 2D 4-connected <b>sql</b> topology layer and a 3D 6-connected <b>rob</b> topology framework. Compound 2 exhibits a rare meso-helices 3D network with different chiralities crossing coexistence. Compound 3 also holds a 3D framework formed by linking terminal oxygen atoms of [α-PMo<sub>12</sub>O<sub>40</sub>]<sup>3-</sup> anions and silver ions in a 2D metal-organic layer. Compound 1 displays antiferromagnetic behavior. The luminescence, electrochemical and photocatalytic properties of compounds 1-3 have also been investigated. Compound 3 exhibits significant electrochemical activity for the reduction of H<sub>2</sub>O<sub>2</sub> while compounds 1 and 2 show efficient photocatalytic activities for the degradation of Rhodamine B (RhB). Furthermore, the three compounds display luminescence behaviors in the solid state.","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Apr","modification":"2025-05-18T12:07:37.478Z","creation":"2025-04-06T22:55:14.155Z"},"accession":"S-EPMC9063552","cross_references":{"pubmed":["35517018"],"doi":["10.1039/c9ra01451a"]}}